Sorbent Therapy of the Cutaneous Porphyrias
NCT01422915
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Erythropoietic Protoporphyria
Interventions
DRUG:
Colestipol
Sponsor
Brigham and Women's Hospital